Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EAA and Low Sugar Diet for MASLD in Youth
NCT07459504Phase 2Recruiting
- Sponsor
- Michigan State University
- Start
- Jun 2026
- Primary completion
- Dec 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of essential amino acids-University of Oregon in metabolic dysfunction-associated steatotic liver disease (MASLD), sponsored by Michigan State University. Started Jun 2026; status: recruiting.
02
Drugs
essential amino acids-University of Oregon
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on NCT07459504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07459504.